During the last session, Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI)’s traded shares were 48314.0, with the beta value of the company hitting 0.53. At the end
Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 0.48. At the close
Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI)’s traded shares stood at 5.98 million during the last session, with the company’s beta value hitting 0.38. At the close
Brainstorm Cell Therapeutics, Inc (NASDAQ:BCLI)’s traded shares stood at 5.33 million during the latest session, with the company’s beta value hitting 0.38. At the last
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
